BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27055353)

  • 41. Community rating and choice between traditional health insurance and managed care.
    Kifmann M
    Health Econ; 1999 Nov; 8(7):563-78. PubMed ID: 10544324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk selection in a regulated health insurance market: a review of the concept, possibilities and effects.
    van Kleef RC; van de Ven WP; van Vliet RC
    Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):743-52. PubMed ID: 24219050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Demand-side strategies to deal with moral hazard in public insurance for long-term care.
    Bakx P; Chernichovsky D; Paolucci F; Schokkaert E; Trottmann M; Wasem J; Schut F
    J Health Serv Res Policy; 2015 Jul; 20(3):170-6. PubMed ID: 25770020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reinvention of health insurance in the consumer era.
    Robinson JC
    JAMA; 2004 Apr; 291(15):1880-6. PubMed ID: 15100208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Switching rates in health insurance markets decrease with age: empirical evidence and policy implications from the Netherlands.
    Duijmelinck DM; van de Ven WP
    Health Econ Policy Law; 2016 Apr; 11(2):141-59. PubMed ID: 26173559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. To what degree do patients actively choose their healthcare provider at the point of referral by their GP? A video observation study.
    Potappel AJC; Meijers MC; Kloek C; Victoor A; Noordman J; Olde Hartman T; van Dulmen S; de Jong JD
    BMC Fam Pract; 2019 Dec; 20(1):166. PubMed ID: 31787107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple choice health insurance: the lessons and challenge to employers.
    Enthoven AC
    Inquiry; 1990; 27(4):368-73. PubMed ID: 2148310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Market Share Matters: Evidence Of Insurer And Provider Bargaining Over Prices.
    Roberts ET; Chernew ME; McWilliams JM
    Health Aff (Millwood); 2017 Jan; 36(1):141-148. PubMed ID: 28069857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expanding choice through defined contributions: overcoming a non-participatory health care economy.
    Moffit RE
    J Law Med Ethics; 2012; 40(3):558-73. PubMed ID: 23061584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HMO consolidation: a threat to network integration?
    Med Netw Strategy Rep; 1999 Nov; 8(11):1-7. PubMed ID: 10724558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cooperation amongst insurers on enhancing quality of care: precondition or substitute for competition?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Econ Policy Law; 2021 Jul; 16(3):273-289. PubMed ID: 32690116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. "Managed competition" for Ireland? The single versus multiple payer debate.
    Mikkers M; Ryan P
    BMC Health Serv Res; 2014 Sep; 14():442. PubMed ID: 25261074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Managed care: the US experience.
    Sekhri NK
    Bull World Health Organ; 2000; 78(6):830-44. PubMed ID: 10916920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New opportunities for provider/insurers. Catholic healthcare organizations are well positioned for direct contracting.
    Unland J
    Health Prog; 1998; 79(3):54-9. PubMed ID: 10180026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advice from the health insurer as a channelling strategy: a natural experiment at a Dutch health insurance company.
    Bes RE; Curfs EC; Groenewegen PP; de Jong JD
    BMC Health Serv Res; 2018 Nov; 18(1):832. PubMed ID: 30400978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is Dutch health care a model for the U.S. health system?
    Frieden J
    Bus Health; 1992 May; 10(6):34-5, 38, 40-2. PubMed ID: 10119118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is the medical loss ratio a good target measure for regulation in the individual market for health insurance?
    Karaca-Mandic P; Abraham JM; Simon K
    Health Econ; 2015 Jan; 24(1):55-74. PubMed ID: 24123608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Results of the market-oriented reform in the Netherlands: a review.
    Maarse H; Jeurissen P; Ruwaard D
    Health Econ Policy Law; 2016 Apr; 11(2):161-78. PubMed ID: 26278627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acceptance of selective contracting: the role of trust in the health insurer.
    Bes RE; Wendel S; Curfs EC; Groenewegen PP; de Jong JD
    BMC Health Serv Res; 2013 Oct; 13():375. PubMed ID: 24083663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. To what degree are health insurance enrollees in the Netherlands aware of the restrictive conditions attached to their policies?
    van der Hulst FJP; Holst L; Brabers AEM; de Jong JD
    Health Policy; 2022 Jul; 126(7):693-703. PubMed ID: 35644719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.